2018 Q3 Form 10-Q Financial Statement

#000143774918020334 Filed on November 09, 2018

View on sec.gov

Income Statement

Concept 2018 Q3 2017 Q3
Revenue $1.562M $1.211M
YoY Change 28.98% 12.03%
Cost Of Revenue $1.038M $946.0K
YoY Change 9.73% -8.42%
Gross Profit $524.0K $265.0K
YoY Change 97.74% 452.08%
Gross Profit Margin 33.55% 21.88%
Selling, General & Admin $1.622M $1.455M
YoY Change 11.48% 0.28%
% of Gross Profit 309.54% 549.06%
Research & Development $420.0K $362.0K
YoY Change 16.02% 110.47%
% of Gross Profit 80.15% 136.6%
Depreciation & Amortization $32.00K $18.00K
YoY Change 77.78% 12.5%
% of Gross Profit 6.11% 6.79%
Operating Expenses $2.042M $1.817M
YoY Change 12.38% 11.95%
Operating Profit -$1.518M -$1.552M
YoY Change -2.19% -1.46%
Interest Expense $10.00K $10.00K
YoY Change 0.0% -83.33%
% of Operating Profit
Other Income/Expense, Net $10.00K $6.000K
YoY Change 66.67% -92.21%
Pretax Income -$1.510M -$1.550M
YoY Change -2.58% 3.33%
Income Tax
% Of Pretax Income
Net Earnings -$1.508M -$1.546M
YoY Change -2.46% 3.2%
Net Earnings / Revenue -96.54% -127.66%
Basic Earnings Per Share
Diluted Earnings Per Share -$22.83K -$28.17K
COMMON SHARES
Basic Shares Outstanding 55.02M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q3 2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $9.190M $7.260M
YoY Change 26.58% -47.05%
Cash & Equivalents $2.193M $3.956M
Short-Term Investments $7.000M $3.300M
Other Short-Term Assets $520.0K $410.0K
YoY Change 26.83% 57.69%
Inventory $487.0K $453.0K
Prepaid Expenses
Receivables $1.070M $740.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $11.27M $8.866M
YoY Change 27.09% -40.62%
LONG-TERM ASSETS
Property, Plant & Equipment $1.394M $1.090M
YoY Change 27.89% 55.71%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $185.0K $217.0K
YoY Change -14.75% -71.82%
Total Long-Term Assets $2.076M $1.915M
YoY Change 8.41% 8.81%
TOTAL ASSETS
Total Short-Term Assets $11.27M $8.866M
Total Long-Term Assets $2.076M $1.915M
Total Assets $13.34M $10.78M
YoY Change 23.77% -35.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.170M $810.0K
YoY Change 44.44% 65.31%
Accrued Expenses $470.0K $260.0K
YoY Change 80.77% -58.73%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.637M $1.067M
YoY Change 53.42% -4.73%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $600.0K $570.0K
YoY Change 5.26% -3.39%
Total Long-Term Liabilities $600.0K $570.0K
YoY Change 5.26% -3.39%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.637M $1.067M
Total Long-Term Liabilities $600.0K $570.0K
Total Liabilities $2.235M $1.635M
YoY Change 36.7% -4.39%
SHAREHOLDERS EQUITY
Retained Earnings -$80.86M -$74.15M
YoY Change 9.04% 9.14%
Common Stock $91.97M $83.30M
YoY Change 10.41% 0.46%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $11.11M $9.146M
YoY Change
Total Liabilities & Shareholders Equity $13.34M $10.78M
YoY Change 23.77% -35.39%

Cashflow Statement

Concept 2018 Q3 2017 Q3
OPERATING ACTIVITIES
Net Income -$1.508M -$1.546M
YoY Change -2.46% 3.2%
Depreciation, Depletion And Amortization $32.00K $18.00K
YoY Change 77.78% 12.5%
Cash From Operating Activities -$1.612M -$1.661M
YoY Change -2.95% 22.76%
INVESTING ACTIVITIES
Capital Expenditures $114.0K $54.00K
YoY Change 111.11% -63.27%
Acquisitions
YoY Change
Other Investing Activities -$6.180M -$260.0K
YoY Change 2276.92% 766.67%
Cash From Investing Activities -$6.289M -$315.0K
YoY Change 1896.51% -3.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $7.494M $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 7.494M
YoY Change
NET CHANGE
Cash From Operating Activities -1.612M -1.661M
Cash From Investing Activities -6.289M -315.0K
Cash From Financing Activities 7.494M
Net Change In Cash -407.0K -1.976M
YoY Change -79.4% 17.62%
FREE CASH FLOW
Cash From Operating Activities -$1.612M -$1.661M
Capital Expenditures $114.0K $54.00K
Free Cash Flow -$1.726M -$1.715M
YoY Change 0.64% 14.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q3 isr Class Of Warrant Or Right Proceeds Upon Exercise
ClassOfWarrantOrRightProceedsUponExercise
4434375
CY2018Q3 isr Noncash Financing Activities Warrants Issued
NoncashFinancingActivitiesWarrantsIssued
163000
CY2017Q3 isr Noncash Financing Activities Warrants Issued
NoncashFinancingActivitiesWarrantsIssued
CY2015Q4 isr Purchase Obligation Agreement Period
PurchaseObligationAgreementPeriod
P1Y
CY2018Q3 isr Research And Development Collaboration Services Net Of Reimbursement
ResearchAndDevelopmentCollaborationServicesNetOfReimbursement
26000
CY2017Q3 isr Research And Development Collaboration Services Net Of Reimbursement
ResearchAndDevelopmentCollaborationServicesNetOfReimbursement
75000
CY2018Q3 isr Research And Development Proprietary Research And Development
ResearchAndDevelopmentProprietaryResearchAndDevelopment
394000
CY2017Q3 isr Research And Development Proprietary Research And Development
ResearchAndDevelopmentProprietaryResearchAndDevelopment
287000
CY2018Q3 isr Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodFairValue
35000
CY2017Q3 isr Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodFairValue
33000
CY2018Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1167000
CY2018Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1391000
CY2018Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
125000
CY2018Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
77000
CY2018Q3 us-gaap Accrued Vacation Current
AccruedVacationCurrent
175000
CY2018Q2 us-gaap Accrued Vacation Current
AccruedVacationCurrent
175000
CY2018Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7698000
CY2018Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7671000
CY2018Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
91898000
CY2018Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
84322000
CY2018Q3 us-gaap Adjustment For Amortization
AdjustmentForAmortization
12000
CY2017Q3 us-gaap Adjustment For Amortization
AdjustmentForAmortization
13000
CY2018Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
93000
CY2017Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
90000
CY2018Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
26000
CY2018Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
26000
CY2018Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9933000
CY2017Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3454000
CY2018Q3 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
8000
CY2017Q3 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
7000
CY2018Q3 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
598000
CY2018Q2 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
590000
CY2018Q3 us-gaap Assets
Assets
13344000
CY2018Q2 us-gaap Assets
Assets
7455000
CY2018Q3 us-gaap Assets Current
AssetsCurrent
11268000
CY2018Q2 us-gaap Assets Current
AssetsCurrent
5446000
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2193000
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2600000
CY2017Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3956000
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2781000
CY2017Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6113000
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2374000
CY2017Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4137000
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-407000
CY2017Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1976000
CY2018Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
5830000
CY2018Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
192998329
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
192998329
CY2018Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
67331147
CY2018Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
56331147
CY2018Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
67331147
CY2018Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
56331147
CY2018Q3 us-gaap Common Stock Value
CommonStockValue
67000
CY2018Q2 us-gaap Common Stock Value
CommonStockValue
56000
CY2018Q3 us-gaap Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
-1000
CY2018Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1038000
CY2017Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
946000
CY2018Q3 us-gaap Depreciation
Depreciation
32000
CY2017Q3 us-gaap Depreciation
Depreciation
18000
CY2018Q3 us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div style="display: inline; font-family: times new roman; font-size: 10pt"><table style=";text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="vertical-align: top; width: 8%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.</div></div></div> </td> <td style="vertical-align: top; width: 92%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">New Accounting </div><div style="display: inline; font-weight: bold;">Standards</div></div> </td> </tr> </table> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">&nbsp;</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 2014, </div>the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> &nbsp; Revenue Recognition, replacing guidance currently codified in Subtopic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">605</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div> Revenue Recognition-Overall with various SEC Staff Accounting Bulletins providing interpretive guidance. The guidance establishes a new <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div> step principle-based framework in an effort to significantly enhance comparability of revenue recognition practices across entities, industries, jurisdictions, and capital markets. The standard became effective for the Company in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of its fiscal year <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019.</div> The Company adopted the new standard in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of fiscal year <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div> and used the modified retrospective method. The adoption of ASU&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div>&nbsp;did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> have a material impact on the consolidated financial statements of the Company and did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> significantly change the timing of revenue recognition compared to the previous methodology.&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02</div> Leases (Subtopic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">842</div>), which will require lessees to recognize assets and liabilities on the balance sheet for the rights and obligations created by most leases. The update is effective for annual and interim reporting periods beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2018. </div>Early adoption is permitted. The ASU will be effective for the Company in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of fiscal year <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2020.</div> We are currently evaluating the impact of the guidance on the Company&#x2019;s consolidated financial statements.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15</div> Statement of Cash Flows (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">230</div>): Classification of Certain Cash Receipts and Cash Payments. The update provides guidance on classification for cash receipts and payments related to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">eight</div> specific issues. The update is effective for fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2017, </div>and interim periods within those fiscal years, with early adoption permitted. The Company&nbsp;adopted&nbsp;ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15</div> as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 1, 2018. </div>The adoption of ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15</div> did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> have a material effect on the Company&#x2019;s consolidated financial statements.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18,</div> &#x201c;Statement of Cash Flows (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">230</div>): Restricted Cash&#x201d;.&nbsp;ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18</div> is intended to clarify how entities present restricted cash in the statement of cash flows. The guidance requires entities to show the changes in the total of cash and cash equivalents and restricted cash in the statement of cash flows. As a result, entities will <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> longer present transfers between cash and cash equivalents and restricted cash in the statement of cash flows. When cash and cash equivalents and restricted cash are presented in more than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> line item on the balance sheet, the new guidance requires a reconciliation of the totals in the statement of cash flows to the related captions in the balance sheet. This reconciliation can be presented either on the face of the statement of cash flows or in the notes to the financial statements. ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18</div> is effective for fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2017 </div>and is to be applied retrospectively. Early adoption is permitted, including adoption in an interim period. The Company adopted ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18</div> in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019.</div> This update resulted in an increase of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$181,000</div> in cash, cash equivalents, and restricted cash at the beginning of the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> period presented on the consolidated statement of cash flows.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Other accounting standards that have been issued or proposed by FASB that do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> require adoption until a future date are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> expected to have a material impact on the consolidated financial statements upon adoption. The Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> discuss recent pronouncements that are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.</div></div>
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2017Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
CY2018Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2018Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
125000
CY2018Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
155000
CY2018Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
615000
CY2018Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y43D
CY2018Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
973000
CY2017Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
841000
CY2018Q3 us-gaap Gross Profit
GrossProfit
524000
CY2017Q3 us-gaap Gross Profit
GrossProfit
265000
CY2018Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-224000
CY2017Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
181000
CY2018Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-121000
CY2017Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
17000
CY2018Q3 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-30000
CY2017Q3 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-104000
CY2018Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-10000
CY2017Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
44000
CY2018Q3 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
48000
CY2017Q3 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-10000
CY2018Q3 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
9000
CY2017Q3 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-114000
CY2018Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7001671
CY2018Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
517000
CY2018Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
335000
CY2018Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
8250000
CY2018Q3 us-gaap Liabilities
Liabilities
2235000
CY2018Q2 us-gaap Liabilities
Liabilities
2425000
CY2018Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
13344000
CY2018Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7455000
CY2018Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1637000
CY2018Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1835000
CY2018Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7494000
CY2017Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
CY2018Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6289000
CY2017Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-315000
CY2018Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1612000
CY2017Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1661000
CY2017Q3 us-gaap Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
8000
CY2018Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
182000
CY2017Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
143000
CY2018Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
37000
CY2018Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
27000
CY2018Q3 us-gaap Inventory Net
InventoryNet
487000
CY2018Q2 us-gaap Inventory Net
InventoryNet
494000
CY2018Q3 us-gaap Inventory Noncurrent
InventoryNoncurrent
316000
CY2018Q2 us-gaap Inventory Noncurrent
InventoryNoncurrent
319000
CY2018Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
348000
CY2018Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
371000
CY2018Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
102000
CY2018Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
96000
CY2018Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
10000
CY2017Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
6000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-1508000
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-1546000
CY2018Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1511000
CY2017Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1549000
CY2018Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
10000
CY2017Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6000
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
2042000
CY2017Q3 us-gaap Operating Expenses
OperatingExpenses
1817000
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1518000
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1552000
CY2018Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
185000
CY2018Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
198000
CY2018Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
45000
CY2018Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
37000
CY2018Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
114000
CY2017Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
54000
CY2018Q3 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
6750000
CY2017Q3 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
3304000
CY2018Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
3000
CY2017Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
3000
CY2018Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7001671
CY2018Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
7494000
CY2017Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
CY2018Q3 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
575000
CY2017Q3 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
3043000
CY2018Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
9092000
CY2018Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8982000
CY2018Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1394000
CY2018Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1311000
CY2018Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
1071000
CY2018Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
1192000
CY2018Q3 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
0
CY2017Q3 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
0
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
420000
CY2017Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
362000
CY2018Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
181000
CY2018Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
181000
CY2017Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
181000
CY2018Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-80856000
CY2018Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-79348000
CY2018Q3 us-gaap Revenues
Revenues
1562000
CY2017Q3 us-gaap Revenues
Revenues
1211000
CY2017Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
614000
CY2018Q3 us-gaap Share Based Compensation
ShareBasedCompensation
93000
CY2017Q3 us-gaap Share Based Compensation
ShareBasedCompensation
90000
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2082000
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.82
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
10000
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
0
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
38750
CY2018Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
649000
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
0.68
CY2018Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y200D
CY2018Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P6Y54D
CY2018Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y200D
CY2018Q3 us-gaap Short Term Investments
ShortTermInvestments
7000000
CY2018Q2 us-gaap Short Term Investments
ShortTermInvestments
825000
CY2018Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
59666
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
82500
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
75000
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
128000
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3787000
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.69
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
78000
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
128000
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
3779000
CY2017Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
11109000
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
5030000
CY2018Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
66147
CY2017Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
55017

Files In Submission

Name View Source Status
0001437749-18-020334-index-headers.html Edgar Link pending
0001437749-18-020334-index.html Edgar Link pending
0001437749-18-020334.txt Edgar Link pending
0001437749-18-020334-xbrl.zip Edgar Link pending
ex_127823.htm Edgar Link pending
ex_127824.htm Edgar Link pending
ex_127825.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
isr-20180930.xml Edgar Link completed
isr-20180930.xsd Edgar Link pending
isr-20180930_cal.xml Edgar Link unprocessable
isr-20180930_def.xml Edgar Link unprocessable
isr-20180930_lab.xml Edgar Link unprocessable
isr-20180930_pre.xml Edgar Link unprocessable
isr20180930_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending